Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cation Transport Proteins | 3 | 2023 | 96 | 2.260 |
Why?
|
| Iron | 3 | 2023 | 267 | 1.450 |
Why?
|
| Shaker Superfamily of Potassium Channels | 3 | 2012 | 31 | 0.990 |
Why?
|
| Hepcidins | 2 | 2023 | 20 | 0.920 |
Why?
|
| Hemochromatosis | 1 | 2023 | 32 | 0.820 |
Why?
|
| Cortisone | 2 | 2012 | 11 | 0.720 |
Why?
|
| Cryoelectron Microscopy | 1 | 2020 | 214 | 0.640 |
Why?
|
| Calcium | 1 | 2023 | 1095 | 0.580 |
Why?
|
| Potassium Channels, Voltage-Gated | 3 | 2004 | 59 | 0.490 |
Why?
|
| Binding Sites | 5 | 2023 | 1296 | 0.480 |
Why?
|
| NADP | 2 | 2011 | 48 | 0.440 |
Why?
|
| Potassium Channel Blockers | 2 | 2003 | 83 | 0.420 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2011 | 36 | 0.360 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2012 | 316 | 0.340 |
Why?
|
| Models, Molecular | 8 | 2020 | 1075 | 0.320 |
Why?
|
| Hippocampus | 3 | 2004 | 830 | 0.320 |
Why?
|
| Kv1.2 Potassium Channel | 1 | 2008 | 12 | 0.310 |
Why?
|
| Aldehyde Reductase | 1 | 2008 | 17 | 0.300 |
Why?
|
| Potassium Channels | 3 | 2020 | 157 | 0.290 |
Why?
|
| Rats | 6 | 2011 | 3686 | 0.250 |
Why?
|
| Membrane Potentials | 3 | 2020 | 304 | 0.250 |
Why?
|
| Protein Binding | 3 | 2020 | 1750 | 0.240 |
Why?
|
| Ion Transport | 3 | 2020 | 52 | 0.230 |
Why?
|
| Phenylcarbamates | 1 | 2003 | 15 | 0.220 |
Why?
|
| Neurons | 2 | 2004 | 1966 | 0.220 |
Why?
|
| Carbamates | 1 | 2003 | 60 | 0.210 |
Why?
|
| Galantamine | 1 | 2003 | 10 | 0.210 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2003 | 34 | 0.210 |
Why?
|
| Electrophysiology | 3 | 2011 | 270 | 0.210 |
Why?
|
| Amyloid beta-Peptides | 1 | 2004 | 210 | 0.200 |
Why?
|
| Ion Channel Gating | 3 | 2013 | 123 | 0.190 |
Why?
|
| Pyramidal Cells | 1 | 2003 | 169 | 0.190 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2020 | 188 | 0.180 |
Why?
|
| Bacterial Proteins | 3 | 2020 | 886 | 0.180 |
Why?
|
| Membrane Transport Proteins | 2 | 2012 | 177 | 0.170 |
Why?
|
| Peptide Fragments | 1 | 2004 | 749 | 0.170 |
Why?
|
| Crystallography, X-Ray | 5 | 2013 | 357 | 0.170 |
Why?
|
| Vibrio parahaemolyticus | 3 | 2020 | 7 | 0.160 |
Why?
|
| Escherichia coli Proteins | 2 | 2020 | 305 | 0.160 |
Why?
|
| Homeostasis | 1 | 2023 | 692 | 0.150 |
Why?
|
| Oxidation-Reduction | 2 | 2011 | 442 | 0.150 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2020 | 133 | 0.150 |
Why?
|
| RNA, Messenger | 1 | 2004 | 2824 | 0.140 |
Why?
|
| Animals | 8 | 2020 | 34153 | 0.140 |
Why?
|
| Alzheimer Disease | 1 | 2004 | 786 | 0.140 |
Why?
|
| Patch-Clamp Techniques | 2 | 2008 | 280 | 0.120 |
Why?
|
| Escherichia coli | 1 | 2020 | 985 | 0.110 |
Why?
|
| Yersinia | 1 | 2013 | 4 | 0.110 |
Why?
|
| Cloning, Molecular | 2 | 2012 | 892 | 0.100 |
Why?
|
| Fluticasone | 1 | 2012 | 15 | 0.100 |
Why?
|
| Brain | 1 | 2004 | 3003 | 0.100 |
Why?
|
| Androstadienes | 1 | 2012 | 49 | 0.100 |
Why?
|
| Rats, Wistar | 2 | 2003 | 360 | 0.100 |
Why?
|
| Xenopus laevis | 2 | 2012 | 125 | 0.100 |
Why?
|
| Bacillus cereus | 1 | 2011 | 8 | 0.090 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 412 | 0.090 |
Why?
|
| Drug Design | 1 | 2012 | 146 | 0.090 |
Why?
|
| Substrate Specificity | 2 | 2011 | 290 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2012 | 124 | 0.090 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2011 | 87 | 0.090 |
Why?
|
| Humans | 6 | 2023 | 124307 | 0.090 |
Why?
|
| DNA Primers | 1 | 2011 | 660 | 0.080 |
Why?
|
| HEK293 Cells | 1 | 2012 | 753 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1017 | 0.080 |
Why?
|
| Xenopus | 1 | 2008 | 107 | 0.080 |
Why?
|
| Binding, Competitive | 1 | 2008 | 185 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2013 | 1024 | 0.080 |
Why?
|
| Amino Acid Sequence | 2 | 2011 | 2701 | 0.070 |
Why?
|
| Molecular Structure | 1 | 2008 | 290 | 0.070 |
Why?
|
| Hydrogen Peroxide | 1 | 2008 | 113 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 1584 | 0.070 |
Why?
|
| Genetic Vectors | 1 | 2011 | 940 | 0.070 |
Why?
|
| Molecular Sequence Data | 2 | 2011 | 3875 | 0.070 |
Why?
|
| Adenosine Diphosphate | 2 | 2020 | 58 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2008 | 624 | 0.070 |
Why?
|
| Biological Transport | 2 | 2020 | 346 | 0.070 |
Why?
|
| Adenosine Triphosphate | 2 | 2020 | 284 | 0.060 |
Why?
|
| Oocytes | 1 | 2008 | 284 | 0.060 |
Why?
|
| Kidney | 1 | 2012 | 1345 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2020 | 833 | 0.060 |
Why?
|
| Potassium | 2 | 2020 | 279 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 1762 | 0.060 |
Why?
|
| Shab Potassium Channels | 1 | 2004 | 2 | 0.060 |
Why?
|
| Delayed Rectifier Potassium Channels | 1 | 2004 | 4 | 0.060 |
Why?
|
| Kv1.4 Potassium Channel | 1 | 2004 | 3 | 0.060 |
Why?
|
| Kv1.5 Potassium Channel | 1 | 2004 | 8 | 0.060 |
Why?
|
| Injections, Intraventricular | 1 | 2004 | 64 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2008 | 795 | 0.060 |
Why?
|
| Shal Potassium Channels | 1 | 2004 | 45 | 0.060 |
Why?
|
| Maze Learning | 1 | 2004 | 128 | 0.060 |
Why?
|
| Rivastigmine | 1 | 2003 | 17 | 0.060 |
Why?
|
| Protein Structure, Quaternary | 2 | 2013 | 98 | 0.050 |
Why?
|
| Memory Disorders | 1 | 2004 | 236 | 0.050 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2003 | 100 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2004 | 862 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 287 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 1228 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2004 | 455 | 0.050 |
Why?
|
| Structure-Activity Relationship | 2 | 2013 | 572 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2013 | 756 | 0.040 |
Why?
|
| X-Ray Diffraction | 1 | 2020 | 96 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1685 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2020 | 137 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2020 | 347 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2020 | 528 | 0.040 |
Why?
|
| Rotation | 1 | 2013 | 51 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2004 | 4356 | 0.030 |
Why?
|
| Male | 3 | 2004 | 60964 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 2013 | 89 | 0.030 |
Why?
|
| Osmosis | 1 | 2012 | 14 | 0.030 |
Why?
|
| Sodium | 1 | 2013 | 294 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2012 | 101 | 0.020 |
Why?
|
| Metabolism | 1 | 2012 | 42 | 0.020 |
Why?
|
| Protein Folding | 1 | 2013 | 218 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2013 | 459 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2012 | 104 | 0.020 |
Why?
|
| Liposomes | 1 | 2012 | 170 | 0.020 |
Why?
|
| Urea | 1 | 2012 | 226 | 0.020 |
Why?
|
| Bile Acids and Salts | 1 | 2013 | 245 | 0.020 |
Why?
|
| Crystallization | 1 | 2011 | 83 | 0.020 |
Why?
|
| Cattle | 1 | 2012 | 563 | 0.020 |
Why?
|
| Carbohydrate Metabolism | 1 | 2011 | 56 | 0.020 |
Why?
|
| Ligands | 1 | 2012 | 536 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 1625 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2867 | 0.020 |
Why?
|
| Proteins | 1 | 2012 | 1045 | 0.020 |
Why?
|
| Female | 1 | 2008 | 66236 | 0.010 |
Why?
|